No Data
US Stock MarketDetailed Quotes
AADI Aadi Biosciences
Watchlist
5.220
-0.020-0.38% Close 09/27 16:00 ET
5.2200.0000.00%
Post 16:03 ET
5.440High5.180Low79.75KVolume
5.280Open5.240Pre Close424.10KTurnover0.51%Turnover RatioLossP/E (TTM)127.99MMarket Cap14.77252wk HighLossP/E (Static)24.52MShares4.90052wk Low0.97P/B81.85MFloat Cap65.250Historical High--Dividend TTM15.68MShs Float4.900Historical Low--Div YieldTTM4.96%Amplitude5.317Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
About Aadi Biosciences Company
Aadi Bioscience, Inc. operates as a clinical-stage biopharmaceutical company. It develops precision therapies for genetically-defined cancers patients with mTOR pathway driver alterations such as alterations in TSC1 or TSC2 genes. The company was founded by Neil Desai on November 2007 and is headquartered in Los Angeles, CA.
Revenue Breakdown
Business
Unit:USD
12/31/2022
Stock NameRevenueRatio
Single Segment15.22M100.00%
News
Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
LOS ANGELES, Sept. 20, 2023 /PRNewswire/ -- Aadi Bioscience, Inc. (NASDAQ:AADI), a biopharmaceutical company focused on developing and commercializing precision therapies for patients with mTOR pathway alterations, today
Aadi Biosciences(AADI.US) Officer Sells US$238.83K in Common Stocks
$Aadi Biosciences(AADI.US)$ Officer Desai Neil sold 42,000 shares of Common Stocks on Sep 1, 5, 6, 2023 at an average price of $5.6863 for a total value of $238.83K.Source: Announcement What is statem
We're Not Very Worried About Aadi Bioscience's (NASDAQ:AADI) Cash Burn Rate
Comments
ColumnsToday's pre-market stock movers: DELL, ULTA, COST, GPS and more
Gainer:
• $Red Robin(RRGB.US$ +13.8% (In reaction to earnings)
• $PMV Pharmaceuticals(PMVP.US$ +11.2% (ASCO-related announcement)
• $Sumo Logic(SUMO.US$ +10.8% (In reaction to earnings)
• $Adicet Bio(ACET.US$ +9.6% (ASCO-related announcement)
• $Dell Technologies(DELL.US$ +9.6% (In reaction to earnings)
• $ImmunoGen(IMGN.US$ +8.7% (ASCO-related announcement)
• $Ulta Beauty(ULTA.US$ +7.9% (In reaction to earnings)
• $Zymergen(ZY.US$ +7.8% (to...
• $Red Robin(RRGB.US$ +13.8% (In reaction to earnings)
• $PMV Pharmaceuticals(PMVP.US$ +11.2% (ASCO-related announcement)
• $Sumo Logic(SUMO.US$ +10.8% (In reaction to earnings)
• $Adicet Bio(ACET.US$ +9.6% (ASCO-related announcement)
• $Dell Technologies(DELL.US$ +9.6% (In reaction to earnings)
• $ImmunoGen(IMGN.US$ +8.7% (ASCO-related announcement)
• $Ulta Beauty(ULTA.US$ +7.9% (In reaction to earnings)
• $Zymergen(ZY.US$ +7.8% (to...
11
3
$Aadi Biosciences(AADI.US$ Nov 26 hopefully fda approval...price target 49 dollars...let's do this
2
Read more
Paper Trade
Start
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--